Loading clinical trials...
Loading clinical trials...
Study Hypothesis: Safety and Tolerability will differ when treating multiple contiguous 25 cm2 treatment areas, as compared to individual 25 cm2 treatment areas.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Peplin
NCT07340697 · Actinic Keratosis (AK)
NCT06778434 · Actinic Keratosis, Imipramine, and more
NCT07137819 · Actinic Keratosis of Face and Scalp
NCT06648447 · Actinic Keratosis (AK)
NCT05688904 · Imipramine, Photodynamic Therapy, and more
Radiant Research
Tucson, Arizona
Skin Surgery Medical Group Inc.
San Diego, California
Park Avenue Dermatology
Orange Park, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions